Cargando…
Neuroprotection in Parkinson’s disease: facts and hopes
Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide. Behind the symptoms there is a complex pathological mechanism which leads to a dopaminergic cell loss in the substantia nigra pars compacta. Despite the strong efforts, curative treatment has not been found yet....
Autores principales: | Salamon, András, Zádori, Dénes, Szpisjak, László, Klivényi, Péter, Vécsei, László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242234/ https://www.ncbi.nlm.nih.gov/pubmed/31828513 http://dx.doi.org/10.1007/s00702-019-02115-8 |
Ejemplares similares
-
Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy
por: Fakan, Bernadett, et al.
Publicado: (2020) -
Clinical parameters predict the effect of bilateral subthalamic stimulation on dynamic balance parameters during gait in Parkinson's disease
por: Kelemen, Andrea, et al.
Publicado: (2022) -
Clinicopathological Relationships in an Aged Case of DOORS Syndrome With a p.Arg506X Mutation in the ATP6V1B2 Gene
por: Zádori, Dénes, et al.
Publicado: (2020) -
Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines
por: Zádori, Dénes, et al.
Publicado: (2011) -
Modulation of cortical resting state functional connectivity during a visuospatial attention task in Parkinson's disease
por: Veréb, Dániel, et al.
Publicado: (2022)